Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 5,860 + 0.34 + web  Related to the article below (Last Update: 8/4/2008)

Corning Announces Second-Quarter Results
MarketWatch - Jul 30, 2008
To listen to a live audio webcast of the call, go to Corning's Web site at www.corning.com/investor_relations and follow the instructions. ...GLW
Source: Google News

Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling … -
A Wolf-Yadlin, S Hautaniemi, DA Lauffenburger, FM … - Proceedings of the National Academy of Sciences, 2007 - National Acad Sciences
... 14 | 5860-5865 ... to fit the MRM and IDA data to a binomial distribution, with success
probability P of 0.88 [95% CI: (0.831, 0.920)] for MRM and 0.34 [95% CI ...

Protein Data Bank depositions from synchrotron sources -
J Jiang, RM Sweet - logo, 2004 - dx.doi.org
... In this web-based database, all PDB entries among individual synchrotron beamlines
are archived, synchronized with the weekly PDB release. ...

[PDF] Catalog of 156 confirmed extrasolar planets and their 133 parent stars -
J Espresate - Arxiv preprint astro-ph/0508317, 2005 - arxiv.org
... On each case I decided to take the data as reported by the discoverers either on
the web or on the paper itself. ... 9 HD46375 1 K 1 V 1.0 1.0 5770 0.34 - 1.0 - 1 ...
-

Electronic communication in ?chain-like? trimetallic ruthenium complexes with two C 7 carbon-rich … -
C Olivier, S Choua, P Turek, D Touchard, S Rigaut - Chemical Communications, 2007 - rsc.org
... First published on the web 17th May 2007. ... [3b][OTf] 2, ?1.32, ?1.13, 0.34, 0.82 b, ...
energies ( max = 5787 cm ?1 ) with increasing intensity ( = 5860 mol ?1 L ...
-

Grazing during early spring in the Gulf of Aqaba and the northern Red Sea -
U Sommer, UG Berninger, R Boettger-Schnack, A … - Marine Ecology Progress Series, 2002 - int-res.com
... 1.0?2.0 1.77 4200 7 434 2 660 4 708 1970?5860 1640?3420 ... 36 0.50?0.84 Thalassiosira
22?39 0.46?0.86 Gymnodinium 40?56 0.16?0.34 Rhizosolenia 50 ...

-
DW Koenig, LM Kroll - US Patent 7,154,018, 2006 - Google Patents
... 5860 391 A * 1/1999 Maxwell et al 119/173 5,879,341 A 3/1999 Odorzynski et al. ... In
one aspect, the outer cover 20 may be a nonwoven fibrous web constructed to ...
-

[PDF] Molecular dynamics simulations of the properties of cosolvent solutions -
R Chitra, PE Smith - J. Phys. Chem. B, 2000 - www-personal.ksu.edu
... Chem. B 2000, 104, 5854 - 5864 10.1021/jp000558t CCC: $19.00 ? 2000 American Chemical
Society Published on Web 05/27/2000 Page 2. the equations of motion. ...
-

[PDF] In Situ, Vibrationally Resonant Sum Frequency Spectroscopy Study of the Self-Assembly of Dioctadecyl … -
SCY Clayton, LJ Richter, JC Stephenson, KA … - Langmuir, 1998 - physics.nist.gov
... Chem. Soc. 1992, 114, 5860. ... Published 2002 by the American Chemical Society Published
on Web 08/22/2002 Page 2. ... At flow rates of 0.34 mL min -1 and less, an ...
-

[PDF] Energy and sustainable urban transport development in China
X Zhang, X Hu - cicero.uio.no
... Fax: +47 22 85 87 51 E-mail: admin@cicero.uio.no Web: www.cicero ... Figure 1). The total
civil motor vehicle population in Beijing increased from 0.34 million in ...
-

SPECTROSCOPY AND PHOTOMETRY OF STELLAR OBJECTS FROM THE SECOND BYURAKAN SURVEY1 JA STEPANIAN, 2 RF …
JA STEPANIAN - THE ASTRONOMICAL JOURNAL, 2001 - iop.org
Page 1. THE ASTRONOMICAL JOURNAL, 122:3361?3382, 2001 December ( 2001. The American
Astronomical Society. All rights reserved. Printed in USA ...
-

Source: Google Scholar
 
 

FDA Proposes Revised Guidelines On Allowing Seriously Ill People To Use Experimental Medicines

Article Date: 14 Dec 2006 - 8:00 PST
FDA on Monday released a proposal that would ease access to unapproved medications for certain patients and allow pharmaceutical companies to charge patients for the drugs in some cases, the Washington Post reports (Stein, Washington Post, 12/12). Since the 1970s, FDA has made experimental drugs available to individuals or groups of patients under compassionate-use programs.

The new guidelines offer additional details on the circumstances under which experimental drugs can be made available (USA Today, 12/12). Under the new guidelines, FDA would clarify that drugs could be available during all stages of drug development, including during Phase I testing (Bridges, AP/Seattle Post-Intelligencer, 12/11).

The proposal includes measures to allow patients to find out more easily how to access experimental drugs. The guidelines also would give scientists, small research organizations and drug companies a method for calculating how much they can charge patients for the experimental drugs, possibly allowing them to make the treatments available to more people (Washington Post, 12/12).

The rules would allow manufacturers to charge for the cost of making and providing an experimental drug, but they would not be permitted to make a profit (Corbett Dooren, Wall Street Journal, 12/12). The proposed guidelines will be subject to public comment for 90 days.

Article continues below and (thank you)
 
Comments
Janet Woodcock, FDA deputy commissioner for operations, said the FDA's guidelines attempt to find an acceptable balance between helping people with critical medical conditions and protecting patient safety and the drug development process. Woodcock said, "FDA hopes this proposal will increase awareness in the health care community of the range of options available for obtaining experimental drugs for seriously ill patients" (Cohen, Newark Star-Ledger, 12/12). However, some observers worry the regulations could leave patients vulnerable to dangerous medicines and could make it more difficult to recruit patients for clinical trials. Sidney Wolfe of Public Citizen's Health Research Group said, "It seems like it could be unleashing some floodgates that could do more harm than good for a number of people" (Washington Post, 12/12). Others believe the guidelines still are too restrictive. Frank Burroughs, president of the Abigail Alliance for Better Access to Developmental Drugs, said the proposal does not go far enough to ensure quick access to potentially lifesaving treatments (Manor, Chicago Tribune, 12/12).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved
 
 
 
Google
Web www.iconocast.com